# Brain Tumor Investment Fund

Investor in Newton, Massachusetts

## About Brain Tumor Investment Fund

Leveraging the National Brain Tumor Society’s (NBTS) 30 years of experience, expertise, and achievement, the BTIF is a venture philanthropy fund supporting NBTS’s vision to conquer and cure brain tumors by investing in biotechnology, pharmaceutical, and medical device companies. BTIF helps accelerate promising research and bring forward potentially transformative treatments, enabling technologies to improve the lives of patients with a brain tumor.

We seek out and invest in opportunities to extend survival and improve the quality of life for brain tumor patients.

We consider potential investments with strong biological rationale, clear mechanisms of action, and development plans that are both bold and realistic.

Through investment and collaboration with portfolio companies, BTIF brings forward emerging products, technologies, and ideas to the field of neuro-oncology.

We invest in projects poised to ultimately deliver significant financial returns of capital to the fund to enable an evergreen investment fund.

## People

- **John Higgins**, Managing Director

## Key Facts

- **Location:** Newton, Massachusetts
- **Investor Type:** Venture Capital

## Investment Industries

- Biotech
- Medical/Healthcare

## How to Contact

Direct messaging, this investor's website, and their LinkedIn profile are available with a paid Ask For Funding plan.

- [See plans and pricing](https://askforfunding.com/pricing)
- Already on a paid plan? [Log in](https://askforfunding.com/users/sign_in)

## More on Ask For Funding

- Full profile: https://askforfunding.com/investor/brain-tumor-investment-fund
- More investors: [Biotech Investors in Massachusetts](https://askforfunding.com/site/angel-investors/massachusetts/biotech)
- Find more investors: https://askforfunding.com/search/investors

Ask For Funding (AskForFunding.com) connects entrepreneurs with angel investors, private investors and venture capital firms in the United States, Canada and Australia.
